Asklepios Kliniken GmbH & Co. KGaA

Nominations for the Broermann Medical Innovation Award 2026 now open

Share
  • With a million euros, it is one of the world’s most highly endowed awards for medical research

Hamburg, 4. September 2025. The nomination period for the Broermann Medical Innovation Award 2026 has begun. Endowed with a million euros, this international award is among the most prestigious honors for medical research worldwide. Scientists from around the globe who have made pioneering contributions in medicine, biotechnology, or related fields may be nominated. The nomination portal will remain open until March 1, 2026. 

The Broermann Medical Innovation Award recognizes scientific breakthroughs with high innovation potential for clinical application. The focus is on research results that have a long-lasting impact on the lives and health of millions of people worldwide. The announcement of the award recipient and the second official Broermann Medical Innovation Award ceremony will take place in autumn 2026. 

Debut of the Broermann Medical Innovation Award This Year 

The award will be presented for the first time this year. The jury will announce the inaugural recipient of the Broermann Medical Innovation Award on September 18, 2025. The official award ceremony, hosted by the Minister-President of Hesse, Boris Rhein, will take place on November 14, 2025, at the Hessian State Chancellery in Wiesbaden. 

Keywords

Contacts

Broermann Medical Innovation Award
Contact: Mirjam Malko
Tel.: +49 (0) 641 / 985-42310
E-Mail: contact@broermann-award.org

Asklepios Kliniken
Konzernbereich Unternehmenskommunikation & Marketing
Tel.: +49 (0) 40 / 18 18-82 66 36
E-Mail: presse@asklepios.com
24-hour press office hotline:+49 (0) 40 / 1818-82 8888

Links

About the Award

The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, founder of the Asklepios Kliniken Group. The award is endowed by Broermann gemeinnützige GmbH and organized through the University Hospital Gießen and Marburg (UKGM). The award is intended to recognize groundbreaking medical discoveries and highlight those whose research is making real progress in the prevention or treatment of disease. The aim is to reflect the award founder's firm conviction that, although scientific excellence in medicine is always an international team effort, the impact of networks is limited without the genius of individual researchers. The Broermann Medical Innovation Award is intended to recognize and support these key figures and drivers of medical innovation worldwide.

Further information about the award, nomination criteria, and selection process can be found on the award website

Subscribe to releases from Asklepios Kliniken GmbH & Co. KGaA

Subscribe to all the latest releases from Asklepios Kliniken GmbH & Co. KGaA by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Asklepios Kliniken GmbH & Co. KGaA

Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award18.11.2025 17:00:00 EET | Press release

Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical achievements visible – and honor those who, with courage, vision, and humanity, are shaping the medicine of tomorrow.”

Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 202518.9.2025 14:31:13 EEST | Press release

With prize money of one million euros, it is one of the most highly endowed medical awards in the world Awarded for groundbreaking pioneering work in cancer therapy using CAR-T cells Award Ceremony with Hessian Prime Minister Boris Rhein Giessen, September 18, 2025. The jury of the Broermann Medical Innovation Award (BMIA) is honoring Dr. Carl June (University of Pennsylvania) and Dr. Michel Sadelain (Columbia University) for their groundbreaking research in the field of CAR-T cell therapy. The Broermann Medical Innovation Award is being presented for the first time this year. With prize money of one million euros, it is among the most highly endowed awards for medical research worldwide.

Nomination period for the Broermann Medical Innovation Award started17.1.2025 13:31:23 EET | Press release

Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields Gießen, January 17, 2025. The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is aimed at scientists worldwide who have carried out pioneering work in medicine, biotechnology, or related fields with their research. The nomination portal (www.broermann-award.org/nomination/) is open until March 1, 2025. At one million euros, the prize is more valuable than the Nobel Prize for Medicine, making it one of the most highly endowed awards for medical research worldwide.

World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye